Clinical Trials Logo

Thyroid Papillary Carcinoma clinical trials

View clinical trials related to Thyroid Papillary Carcinoma.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04411290 Enrolling by invitation - Thyroid Nodule Clinical Trials

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

Start date: May 15, 2020
Phase:
Study type: Observational

In the last decades, thyroid cancer incidence has continuously increased all over the world, almost exclusively due to a sharp rise in the incidence of the papillary histologic subtype, which has the highest incidence of multifocality. Furthermore, Black Sea and Eastern European regions are both endemic and known to have been under the influence of Chernobyl nuclear explosion. Although overscreening might have a role in certain parts of the world, the predictors of malignancy such as family history, genetical disorders, previous radiation exposure, low iodine intake, diabetes and obesity, should also be taken into consideration in determining the extent of surgery.